Open AccessReactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine
Author(s) -
Tao Tao
Publication year - 2022
Publication title -
cutis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.289
H-Index - 53
eISSN - 2326-6929
pISSN - 0011-4162
DOI - 10.12788/cutis.0470
Subject(s) - medicine , vaccination , covid-19 , pandemic , virology , bcg vaccine , attenuated vaccine , immunology , pathology , outbreak , disease , infectious disease (medical specialty) , biochemistry , chemistry , virulence , gene
The devastating effects of the COVID-19 pandemic have prompted rapid development and distribution of multiple vaccines. A 2-dose messenger RNA (mRNA) vaccine developed by Moderna (Moderna COVID-19 Vaccine) was approved in December 2020 for the prevention of COVID-19. We describe a case of BCG vaccination scar reactivation in a 48-year-old man after he received the first dose of the Moderna COVID-19 Vaccine.